25 XP   0   0   10

Revive Therapeutics Ltd
Buy, Hold or Sell?

Let's analyse Revive Therapeutics Ltd together

PenkeI guess you are interested in Revive Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Revive Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Revive Therapeutics Ltd

I send you an email if I find something interesting about Revive Therapeutics Ltd.

Quick analysis of Revive Therapeutics Ltd (30 sec.)










What can you expect buying and holding a share of Revive Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.02
Expected worth in 1 year
€0.01
How sure are you?
57.1%

+ What do you gain per year?

Total Gains per Share
€-0.01
Return On Investment
-98.7%

For what price can you sell your share?

Current Price per Share
€0.02
Expected price per share
€0.01 - €0.03
How sure are you?
50%

1. Valuation of Revive Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)

€0.02

Intrinsic Value Per Share

€-0.22 - €-0.19

Total Value Per Share

€-0.20 - €-0.17

2. Growth of Revive Therapeutics Ltd (5 min.)




Is Revive Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$7.8m$9.2m-$1.4m-18.3%

How much money is Revive Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$4.6m-$13.1m$8.4m181.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Revive Therapeutics Ltd (5 min.)




What can you expect buying and holding a share of Revive Therapeutics Ltd? (5 min.)

Welcome investor! Revive Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Revive Therapeutics Ltd.

What can you expect buying and holding a share of Revive Therapeutics Ltd?

First you should know what it really means to hold a share of Revive Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Revive Therapeutics Ltd is €0.015. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Revive Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Revive Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.02. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Revive Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.01-86.5%-0.01-86.5%-0.04-243.8%-0.02-139.6%-0.02-106.4%
Usd Book Value Change Per Share0.00-26.7%0.00-26.7%-0.03-221.9%0.0026.9%0.0020.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-26.7%0.00-26.7%-0.03-221.9%0.0026.9%0.0020.8%
Usd Price Per Share0.02-0.02-0.37-0.22-0.20-
Price to Earnings Ratio-1.87--1.87--10.00--12.37--20.33-
Price-to-Total Gains Ratio-6.05--6.05--10.99-39.93-23.06-
Price to Book Ratio1.11-1.11-14.12-12.91-26.87-
Price-to-Total Gains Ratio-6.05--6.05--10.99-39.93-23.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0162255
Number of shares61631
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (61631 shares)-246.85248.90
Gains per Year (61631 shares)-987.39995.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-987-9970996986
20-1975-1984019911982
30-2962-2971029872978
40-3950-3958039823974
50-4937-4945049784970
60-5924-5932059745966
70-6912-6919069696962
80-7899-7906079657958
90-8887-8893089608954
100-9874-9880099569950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.00.00.0%0.07.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%

Fundamentals of Revive Therapeutics Ltd

About Revive Therapeutics Ltd

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.

Fundamental data was last updated by Penke on 2024-03-09 23:12:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Revive Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Revive Therapeutics Ltd earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Revive Therapeutics Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Revive Therapeutics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.1.2. Return on Assets

Shows how efficient Revive Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Revive Therapeutics Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -44.4% Return on Assets means that Revive Therapeutics Ltd generated €-0.44 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Revive Therapeutics Ltd:

  • The MRQ is -44.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -44.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-44.4%TTM-44.4%0.0%
TTM-44.4%YOY-104.3%+60.0%
TTM-44.4%5Y-77.2%+32.9%
5Y-77.2%10Y-90.0%+12.8%
1.1.3. Return on Equity

Shows how efficient Revive Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Revive Therapeutics Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -59.3% Return on Equity means Revive Therapeutics Ltd generated €-0.59 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Revive Therapeutics Ltd:

  • The MRQ is -59.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -59.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.3%TTM-59.3%0.0%
TTM-59.3%YOY-141.3%+82.0%
TTM-59.3%5Y-96.6%+37.2%
5Y-96.6%10Y-114.4%+17.9%

1.2. Operating Efficiency of Revive Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Revive Therapeutics Ltd is operating .

  • Measures how much profit Revive Therapeutics Ltd makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Revive Therapeutics Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Revive Therapeutics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Revive Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000

1.3. Liquidity of Revive Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Revive Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.68 means the company has €0.68 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.685. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.685. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.685TTM0.6850.000
TTM0.685YOY0.999-0.315
TTM0.6855Y7.446-6.762
5Y7.44610Y6.716+0.730
1.3.2. Quick Ratio

Measures if Revive Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Revive Therapeutics Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.046-0.046
TTM-5Y0.201-0.201
5Y0.20110Y0.145+0.056

1.4. Solvency of Revive Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Revive Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Revive Therapeutics Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.25 means that Revive Therapeutics Ltd assets are financed with 25.3% credit (debt) and the remaining percentage (100% - 25.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.253. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.253. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.2530.000
TTM0.253YOY0.262-0.009
TTM0.2535Y0.180+0.073
5Y0.18010Y0.190-0.010
1.4.2. Debt to Equity Ratio

Measures if Revive Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Revive Therapeutics Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 33.8% means that company has €0.34 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.338. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.338. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.338TTM0.3380.000
TTM0.338YOY0.354-0.016
TTM0.3385Y0.235+0.103
5Y0.23510Y0.247-0.012

2. Market Valuation of Revive Therapeutics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Revive Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Revive Therapeutics Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.87 means the investor is paying €-1.87 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Revive Therapeutics Ltd:

  • The EOD is -1.250. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.866. Based on the earnings, the company is expensive. -2
  • The TTM is -1.866. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.250MRQ-1.866+0.617
MRQ-1.866TTM-1.8660.000
TTM-1.866YOY-9.997+8.130
TTM-1.8665Y-12.373+10.507
5Y-12.37310Y-20.333+7.960
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Revive Therapeutics Ltd:

  • The EOD is -1.311. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.958. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.958. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.311MRQ-1.958+0.647
MRQ-1.958TTM-1.9580.000
TTM-1.958YOY-13.630+11.672
TTM-1.9585Y-19.779+17.821
5Y-19.77910Y-25.186+5.407
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Revive Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.11 means the investor is paying €1.11 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Revive Therapeutics Ltd:

  • The EOD is 0.742. Based on the equity, the company is cheap. +2
  • The MRQ is 1.107. Based on the equity, the company is underpriced. +1
  • The TTM is 1.107. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.742MRQ1.107-0.366
MRQ1.107TTM1.1070.000
TTM1.107YOY14.125-13.017
TTM1.1075Y12.906-11.798
5Y12.90610Y26.869-13.963
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Revive Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.0040%-0.031+731%0.004-199%0.003-228%
Book Value Per Share--0.0200.0200%0.024-15%0.023-12%0.017+19%
Current Ratio--0.6850.6850%0.999-32%7.446-91%6.716-90%
Debt To Asset Ratio--0.2530.2530%0.262-3%0.180+40%0.190+33%
Debt To Equity Ratio--0.3380.3380%0.354-5%0.235+44%0.247+37%
Dividend Per Share----0%-0%-0%-0%
Eps---0.012-0.0120%-0.034+182%-0.019+61%-0.015+23%
Free Cash Flow Per Share---0.011-0.0110%-0.025+117%-0.013+13%-0.010-11%
Free Cash Flow To Equity Per Share---0.003-0.0030%-0.024+594%0.001-775%0.000-1284%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.187--------
Intrinsic Value_10Y_min---0.224--------
Intrinsic Value_1Y_max---0.014--------
Intrinsic Value_1Y_min---0.020--------
Intrinsic Value_3Y_max---0.046--------
Intrinsic Value_3Y_min---0.063--------
Intrinsic Value_5Y_max---0.082--------
Intrinsic Value_5Y_min---0.108--------
Market Cap5376705.120-49%8029212.9798029212.9790%121155088.704-93%72542505.479-89%65078614.638-88%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.742-49%1.1071.1070%14.125-92%12.906-91%26.869-96%
Pe Ratio-1.250+33%-1.866-1.8660%-9.997+436%-12.373+563%-20.333+989%
Price Per Share0.015-49%0.0220.0220%0.338-93%0.202-89%0.182-88%
Price To Free Cash Flow Ratio-1.311+33%-1.958-1.9580%-13.630+596%-19.779+910%-25.186+1186%
Price To Total Gains Ratio-4.051+33%-6.050-6.0500%-10.986+82%39.935-115%23.064-126%
Quick Ratio----0%0.046-100%0.201-100%0.145-100%
Return On Assets---0.444-0.4440%-1.043+135%-0.772+74%-0.900+103%
Return On Equity---0.593-0.5930%-1.413+138%-0.966+63%-1.144+93%
Total Gains Per Share---0.004-0.0040%-0.031+731%0.004-199%0.003-228%
Usd Book Value--7842507.1677842507.1670%9278182.785-15%8900993.002-12%6614083.989+19%
Usd Book Value Change Per Share---0.004-0.0040%-0.033+731%0.004-199%0.003-228%
Usd Book Value Per Share--0.0220.0220%0.026-15%0.025-12%0.018+19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.013-0.0130%-0.037+182%-0.021+61%-0.016+23%
Usd Free Cash Flow---4436166.786-4436166.7860%-9615198.302+117%-5020069.834+13%-3963549.666-11%
Usd Free Cash Flow Per Share---0.012-0.0120%-0.027+117%-0.014+13%-0.011-11%
Usd Free Cash Flow To Equity Per Share---0.004-0.0040%-0.026+594%0.001-775%0.000-1284%
Usd Market Cap5815981.928-49%8685199.6808685199.6800%131053459.451-93%78469228.177-89%70395537.454-88%
Usd Price Per Share0.016-49%0.0240.0240%0.366-93%0.219-89%0.196-88%
Usd Profit---4653478.311-4653478.3110%-13109549.048+182%-7505198.199+61%-5719150.853+23%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.004-0.0040%-0.033+731%0.004-199%0.003-228%
 EOD+3 -5MRQTTM+0 -0YOY+19 -105Y+10 -1910Y+10 -19

3.2. Fundamental Score

Let's check the fundamental score of Revive Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.250
Price to Book Ratio (EOD)Between0-10.742
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.685
Debt to Asset Ratio (MRQ)Less than10.253
Debt to Equity Ratio (MRQ)Less than10.338
Return on Equity (MRQ)Greater than0.15-0.593
Return on Assets (MRQ)Greater than0.05-0.444
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Revive Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.300
Ma 20Greater thanMa 500.013
Ma 50Greater thanMa 1000.012
Ma 100Greater thanMa 2000.012
OpenGreater thanClose0.015
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets14,252
Total Liabilities3,599
Total Stockholder Equity10,653
 As reported
Total Liabilities 3,599
Total Stockholder Equity+ 10,653
Total Assets = 14,252

Assets

Total Assets14,252
Total Current Assets2,352
Long-term Assets11,900
Total Current Assets
Cash And Cash Equivalents 2,087
Total Current Assets  (as reported)2,352
Total Current Assets  (calculated)2,087
+/- 265
Long-term Assets
Property Plant Equipment 1
Long Term Investments 163
Intangible Assets 11,723
Long-term Assets  (as reported)11,900
Long-term Assets  (calculated)11,887
+/- 13

Liabilities & Shareholders' Equity

Total Current Liabilities3,436
Long-term Liabilities163
Total Stockholder Equity10,653
Total Current Liabilities
Accounts payable 2,662
Total Current Liabilities  (as reported)3,436
Total Current Liabilities  (calculated)2,662
+/- 773
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt160
Long-term Liabilities  (as reported)163
Long-term Liabilities  (calculated)160
+/- 4
Total Stockholder Equity
Total Stockholder Equity (as reported)10,653
Total Stockholder Equity (calculated)0
+/- 10,653
Other
Capital Stock45,980
Common Stock Shares Outstanding 357,647
Net Invested Capital 10,713
Net Working Capital -1,084
Property Plant and Equipment Gross 15



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
> Total Assets 
1,924
1,120
1,283
8,261
29,806
17,065
14,252
14,25217,06529,8068,2611,2831,1201,924
   > Total Current Assets 
1,897
1,086
528
2,158
16,795
4,164
2,352
2,3524,16416,7952,1585281,0861,897
       Cash And Cash Equivalents 
1,769
1,061
475
1,381
16,600
3,916
2,087
2,0873,91616,6001,3814751,0611,769
       Short-term Investments 
0
0
0
100
0
0
0
000100000
       Net Receivables 
2
0
0
178
127
191
0
0191127178002
   > Long-term Assets 
26
34
754
6,102
13,012
12,901
11,900
11,90012,90113,0126,1027543426
       Property Plant Equipment 
6
6
4
3
2
2
1
1223466
       Long Term Investments 
0
0
750
250
250
250
163
16325025025075000
       Intangible Assets 
21
28
0
5,500
12,500
12,500
11,723
11,72312,50012,5005,50002821
       Other Assets 
0
0
0
349
259
149
0
0149259349000
> Total Liabilities 
309
299
322
832
1,000
4,463
3,599
3,5994,4631,000832322299309
   > Total Current Liabilities 
309
299
322
372
598
4,166
3,436
3,4364,166598372322299309
       Accounts payable 
237
213
200
210
436
3,916
2,662
2,6623,916436210200213237
   > Long-term Liabilities 
0
0
0
459
402
296
163
163296402459000
       Other Liabilities 
0
0
0
64
74
77
0
0777464000
> Total Stockholder Equity
1,615
821
961
7,429
28,807
12,603
10,653
10,65312,60328,8077,4299618211,615
   Common Stock
7,449
8,424
9,352
19,126
42,430
43,113
0
043,11342,43019,1269,3528,4247,449
   Retained Earnings -60,568-54,247-36,440-16,321-10,939-9,595-7,805
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
241
9
430
1,403
11,425
11,341
0
011,34111,4251,4034309241



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-5,521
Operating Income-5,521-5,521
 
Operating Expense (+$)
Research Development3,583
Selling General Administrative1,773
Selling And Marketing Expenses0
Operating Expense5,5215,357
 
Net Interest Income (+$)
Interest Income113
Interest Expense-44
Other Finance Cost-4
Net Interest Income65
 
Pretax Income (+$)
Operating Income-5,521
Net Interest Income65
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,321-4,657
EBIT - interestExpense = -44
-6,321
-6,277
Interest Expense44
Earnings Before Interest and Taxes (EBIT)0-6,277
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-6,321
Tax Provision-0
Net Income From Continuing Ops-6,321-6,321
Net Income-6,321
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-865-65
 

Technical Analysis of Revive Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Revive Therapeutics Ltd. The general trend of Revive Therapeutics Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Revive Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Revive Therapeutics Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.016 < 0.024 < 0.03.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Revive Therapeutics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Revive Therapeutics Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Revive Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Revive Therapeutics Ltd. The current macd is 0.00116226.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Revive Therapeutics Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Revive Therapeutics Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Revive Therapeutics Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Revive Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRevive Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Revive Therapeutics Ltd. The current adx is 70.19.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Revive Therapeutics Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Revive Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Revive Therapeutics Ltd. The current sar is 0.01139342.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Revive Therapeutics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Revive Therapeutics Ltd. The current rsi is 58.30. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Revive Therapeutics Ltd Daily Relative Strength Index (RSI) ChartRevive Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Revive Therapeutics Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Revive Therapeutics Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Revive Therapeutics Ltd Daily Stochastic Oscillator ChartRevive Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Revive Therapeutics Ltd. The current cci is 68.39.

Revive Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartRevive Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Revive Therapeutics Ltd. The current cmo is 22.00.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Revive Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartRevive Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Revive Therapeutics Ltd. The current willr is -16.66666667.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Revive Therapeutics Ltd Daily Williams %R ChartRevive Therapeutics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Revive Therapeutics Ltd.

Revive Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Revive Therapeutics Ltd. The current atr is 0.00108634.

Revive Therapeutics Ltd Daily Average True Range (ATR) ChartRevive Therapeutics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Revive Therapeutics Ltd. The current obv is 203,273.

Revive Therapeutics Ltd Daily On-Balance Volume (OBV) ChartRevive Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Revive Therapeutics Ltd. The current mfi is 51.09.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Revive Therapeutics Ltd Daily Money Flow Index (MFI) ChartRevive Therapeutics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Revive Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-16 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-23 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-04 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-26 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-30 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Revive Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Revive Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.300
Ma 20Greater thanMa 500.013
Ma 50Greater thanMa 1000.012
Ma 100Greater thanMa 2000.012
OpenGreater thanClose0.015
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Revive Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Revive Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Revive Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Revive Therapeutics Ltd

I send you an email if I find something interesting about Revive Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Revive Therapeutics Ltd.

Receive notifications about Revive Therapeutics Ltd in your mailbox!